Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014

由 Takagi, Yusuke, Hosomi, Yukio, Oshita, Fumihiro, Okamoto, Hiroaki, Seki, Nobuhiko, Minato, Koichi, Aono, Hiromi, Yamada, Kouzo, Okuma, Yusuke, Hida, Naoya, Sakamoto, Takahiko, Miura, Yosuke, Yomota, Makiko, Satoh, Akira, Kunitoh, Hideo, Sakamaki, Kentaro, Shibuya, Masahiko, Watanabe, Koshiro
發表在 BMC Cancer (2015)

Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation–Positive Non–Small Cell Lung Cancer: A Multicenter Phase 2 Trial

由 Miyamoto, Shingo, Azuma, Koichi, Ishii, Hidenobu, Bessho, Akihiro, Hosokawa, Shinobu, Fukamatsu, Nobuaki, Kunitoh, Hideo, Ishii, Mari, Tanaka, Hiroshi, Aono, Hiromi, Nakahara, Yoshiro, Kusaka, Kei, Hosomi, Yukio, Kikuchi, Norihiro, Mori, Yoshiaki, Itani, Hidetoshi, Hamada, Akinobu, Yamada, Kazuhiko, Okamoto, Hiroaki
發表在 JAMA Oncol (2020)